KeyBanc Starts STERIS (STE) at Buy; Analyst Expects Steady Upward Trajectory
Tweet Send to a Friend
KeyBanc initiated coverage on STERIS (NYSE: STE) with a Buy rating and a price target of $59.00.Analyst Matthew Mishan said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
